Ingredient development
Formulation, standardization, testing or scale-up questions about a botanical ingredient or finished product.
- Product type and target market
- The problem, for example stability or identity testing
- Your timeline
Contact
Start a conversation about ingredient development, supply, research or investment
Choose the pathway closest to your need and send a short first message. Keep confidential details out of it; if a conversation needs them, we will arrange a nondisclosure agreement and a protected channel first.
Status. EUTECNIQ Sciences is a company in formation. It has no laboratory or office open to visitors yet and does not yet accept samples or orders.
Pathways
Six kinds of conversation, each with what a useful first message includes
Choosing a pathway sets the topic on the form below.
International suppliers
Botanical raw materials or extracts that need technical qualification or a route to the U.S. market.
- Material, plant part and origin
- Documentation you already hold
- Typical volumes
Scientific collaboration
Joint work on characterization, delivery systems, computational methods or human evidence.
- Your field and institution
- The research question
- Funding route, if known
Strategic investment
Introductions for qualified parties. Information only; not an offer of securities.
- Your organization
- The type of investor you represent
- Your area of interest
Licensing and technology transfer
Future licensing of know-how, or moving a process between a development laboratory and a manufacturer. EUTECNIQ holds no patents or licensable technology yet.
- The technology or process concerned
- Scale and current stage
- What you would want to license or transfer
General inquiries
Press, partnerships and any question that does not fit the other pathways.
- Who you are
- What you would like to discuss
Send a message
Write to the company by email
Choose the topic that fits; each link opens your email program with the subject filled in. Do not send confidential material; if a conversation needs it, we will arrange a nondisclosure agreement first.
Email [email protected], or start from a topic:
Contact the founder directly
Dr. Amir H. Mehrkesh, Founder
What happens next
- The founder reads each inquiry.
- Replies come by email, usually to arrange a call.
- If confidential information is needed, a nondisclosure agreement and a protected file-sharing channel are agreed first.
- Investor inquiries follow the investor introduction process.